The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...

Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...

Last year, the administration of former President Joe Biden allocated more than $800 million to combat bird flu in livestock.

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...